Mastering Migraine: Examining the Therapeutic Spectrum for Optimal Patient Outcomes

Overview

Treatments targeting calcitonin gene-related peptide (CGRP) effectively treat migraine and have changed our approach to the disorder. This course will review how these medications work and provide updates on their safety and effectiveness. We will particularly focus on differences between monoclonal antibodies and small molecule antagonists against CGRP, acute and preventive treatment, and individualizing therapy for each patient.

Additional Information

AttachmentSize
PDF icon Slides and disclosures5.46 MB
Course summary
Available credit: 
  • 1.00 AANP
    • 0.60 AANP Pharmacology Hours
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
11/01/2021
Course expires: 
11/01/2022
Part of: 
BRAINWeek Track
Rating: 
0

Accreditation

Available Credit

  • 1.00 AANP
    • 0.60 AANP Pharmacology Hours
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA

Register/Take course

Please login or register to take this course.

Required Hardware/software

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.